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Abstract 
Maximally effective concentrations of vanadate (a phosphotyrosine phosphatase inhibitor) increase glucose transport in muscle less 
than maximal insulin stimulation. This might be due to vanadate-induced decreased intrinsic activity of GLUT4 accompanying GLUT4 
translocation. Thus, the effect of vanadate (NaVO 3) on glucose transporter (GLUT4) intrinsic activity (Vma x= intrinsic activity X [GLUT4 
protein]) was studied in muscle plasma membrane giant vesicles. Giant vesicles (average diameter 7.6 p.m) were produced by collagenase 
treatment of rat skeletal muscle. The vesicles were incubated for 1.5 h with concentrations of vanadate ranging from 3 to 40 mmol 1-1 at 
34°C before being used for determination of glucose transport. The dose-response curve showed that vanadate decreased the specific 
o-glucose uptake by a maximum of 70% compared with a control preparation. The vanadate-induced decrease in glucose uptake was not 
due to a decrease in number of vesicles. To further verify the apparent vanadate-induced decrease in GLUT4 intrinsic activity, the kinetics 
of glucose transport were also examined. In the presence of 10 mmol 1-~ vanadate the Vm, x and K m were decreased (P < 0.05, n = 6) 
55% and 60%, respectively, compared with control. The plasma membrane GLUT4 protein content was not changed in response to 
vanadate. It is concluded that vanadate decreased glucose transport per GLUT4 (intrinsic activity). This finding suggests that regulation of 
glucose transport in skeletal muscle can involve changes in GLUT4 intrinsic activity. 
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1. Introduction 
Vanadate (a phosphotyrosine phosphatase inhibitor) 
fully mimics insulin-stimulated glucose transport and 
GLUT4 protein translocation in adipocytes [1-3]. How- 
ever, the vanadate-induced increase in glucose transport is 
lower than a maximal insulin stimulation in skeletal mus- 
cle [4-6]. This might be explained by vanadate decreasing 
the GLUT4 intrinsic activity by inhibiting a phospho- 
tyrosine phosphatase. Furthermore, a substantial number of 
studies [7-19] on glucose transport in adipocytes also 
suggest hat a change in the GLUT4 intrinsic activity by 
phosphorylation is a prerequisite for maximal insulin- 
stimulated glucose uptake. Moreover, it has been shown in 
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skeletal muscle that an increase in cAMP by epinephrine 
administration reduced the glucose uptake by approx. 50% 
despite an increase of GLUT4 proteins in the plasma 
membrane [20]. Dibutyryl cAMP reduced the GLUT4- 
mediated glucose uptake by 50% when GLUT4 was ex- 
pressed in Chinese hamster ovary cells with unaltered 
concentrations of GLUT4 proteins in the plasma mem- 
brane [21]. All taken together, these findings suggest hat 
changes in GLUT4 intrinsic activity could be mediated by 
changes in GLUT4 protein phosphorylation status. 
Intrinsic activity (kcat: catalytic turnover number) is 
defined by Vma x = kca t X [GLUT4 protein] [22]. Thus, mea- 
surements of GLUT4 intrinsic activity in intact skeletal 
muscle require a fixed concentration of GLUT4 proteins in 
the plasma membrane. We used a recently described 
method [23] for producing skeletal muscle plasma mem- 
brane giant vesicles, which enables precise determination 
of vanadate-induced changes in GLUT4 intrinsic activity 
without changes in the GLUT4 protein concentration. 
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2. Materials and methods 
Nycodenz was from Nycomed AS, Norway. Percoll ® 
was from Pharmacia, LKB Sweden. Phloretin, PMSF and 
collagenase (type VII) were from Sigma, St. Louis, USA. 
Aprotinin (Trasylol) was from Bayer, Leverkusen, Ger- 
many. D-[3H]Glucose and L-[14C]glucose were from New 
England Nuclear, Boston, MA. All other chemicals were 
of analytical grade. 
Preparation of plasma membrane vesicles. Plas- 
malemma vesicles were produced by a modification of the 
procedure by Burton et al. [24], as described previously 
[23]. In brief, male Wistar rats (240-260 g), fed ad 
libitum, were anesthetized with sodium pentobarbital (5 
mg per 100 g body weight) and the gastrocnemius-soleus- 
plantaris muscles, together with quadriceps femoris mus- 
cles, from both hindlimbs were removed, and cut longitu- 
dinally into thin slices (1-2 mm) and washed briefly in 
KC1-Hepes buffer (140 mmol 1- l KC1, 5 mmol 1- 1 Hepes, 
pH 7.8) with 0.37 mg ml-I PMSF (phenylmethylsulfonyl 
fluoride) added. Subsequently, the muscle slices were in- 
cubated for 40 min at 34°C in a final volume of 20 ml of 
KCl-Hepes buffer containing 0.041 mg ml-1 highly puri- 
fied collagenase together with the proteinase inhibitors 
aprotinin (0.01 mg m1-1) and PMSF (0.37 mg ml-I). 
During incubation spontaneous formation of vesicles rang- 
ing in diameter from 3-40 /xm occurs. To purify and 
concentrate he vesicles, Percoll was added to the suspen- 
sion of vesicles and cell debris to a final concentration of
16%. The suspension was placed at the bottom of six 
centrifugation tubes and overlayered by 3 ml 4% nycodenz 
(w/v) in KC1-Hepes buffer and by 1 ml of KCl-Hepes 
buffer. The tubes were spun at 40 X g for 45 min at room 
temperature, whereupon the vesicles were harvested be- 
tween the two top layers, diluted in KC1-Hepes buffer and 
pelleted at 830 × g for 30 min. For subsequent protein 
determination the vesicles were stored at -20°C. Protein 
concentrations were determined in duplicate by using the 
bicinchoninic assay [25]. 
Microscopy. Diluted aliquots of membrane vesicles were 
placed in a blood cell counting chamber. The vesicles were 
allowed to settle for 15 min and then examined with a 
Zeiss phase-contrast microscope. 
Measurements ofglucose transport in membrane vesi- 
cles. Glucose transport (influx) was measured at room 
temperature and at zero-trans conditions as described in 
[23]. In brief, 30/xl of membrane vesicles were placed in a 
1.5 ml Eppendorf tube and mixed with 10/xl of a solution 
containing D-[3H]glucose, L-[14C]glucose and various con- 
centrations of unlabelled D-glucose and mannitol in KC1- 
Hepes buffer. Time-course of 5 mmol 1-1 zero-trans D- 
glucose uptake is linear for the first 30 s [23]. Thus, 30 s 
(initial rate of D-glucose uptake) was used when the D-glu- 
cose concentration was varied between 2-40 mmol 1-1 
final concentration. The mannitol concentration was varied 
reciprocally so that the total concentration of sugars was 
40 mmol 1-1. After the designated time, entry of glucose 
was stopped by addition of 1.0 ml ice cold stop solution 
(200 /~mol 1-1 phloretin in KC1-Hepes buffer) and the 
mixture was spun for 1 min in a high speed centrifuge 
(17000 X g). The supernatant was aspirated and the bot- 
tom part of the Eppendorf tube, containing the pellet, was 
cut off and counted with a Packard Tri Carb 2000CA 
liquid scintillation counter. Specific D-glucose uptake was 
calculated after subtracting the distribution space for L-glu- 
cose from the D-glucose space in the pellet [23]. Estimation 
of maximum velocity (Vmax) and the constant K m in the 
Michaelis-Menten equation was done by curve fitting 
using the least-squares method. 
Incubation with vanadate. Because the plasma mem- 
brane proteins in the vesicles are oriented 'right side out' 
[24,26], it was important that vanadate gained access to the 
intravesicular volume. Thus, the vesicles were incubated 
for 1.5 h with different concentrations of NaVO 3 (ranging 
from 3 to 40 mmol l -l ) at 34°C before the vesicles were 
spun down (30 min) and subsequently used for glucose 
transport experiments. It should be noted that vanadate is 
poorly permeable so the actual intravesicular concentration 
can be significantly lower. The control preparation was 
incubated at 34°C with 20 mmol 1-1 mannitol in order to 
avoid a osmotic-induced difference in glucose transport. In 
the dose-response experiment, the vesicles were incubated 
at 34°C with 3-40 mmol 1-1 of NaVO 3 and 0-80 mmol 
1-~ of mannitol so that the total osmotic pressure was 
constant. The glucose uptake (after 1 min) was not differ- 
ent after an incubation with 80 mmol 1-l mannitol com- 
pared with a control preparation i cubated in mannitol-free 
buffer (data not shown). The vesicles were sedimented at 
830 × g for 30 min, and the pellet was resuspended in the 
respective vanadate- or mannitol-buffer before the vesicles 
were used for measurement of glucose transport. 
Western blot. The plasma membrane vesicles were in- 
cubated for 2 h at 34°C in the presence and absence of 10 
mM vanadate. The plasma membrane vesicles were washed 
once in a hypertonic buffer (300 mmol 1-i KC1, 25 mmol 
1- i pyrophosphate, 10mmol 1- 1 Hepes, pH 7.4) followed 
by a wash in a hypotonic buffer (10 mmol 1-1 Tris, pH 
7.4) and pelleted (90 min, 50000 RPM, Beckman 70.1 
Ti-rotor) as described by Ploug et al. [23]. Approximately 
15% of the vesicle protein was recovered as membrane 
protein with no significant difference in membrane protein 
recovery in response to the vanadate treatment. The mem- 
brane proteins were separated using SDS-PAGE, electro- 
transferred to an Immobilon P membrane (Milipore), im- 
munoblotted, and GLUT4 antibody-antigen complexes 
were visualised within the linear range by the enhanced 
chemoluminiscense (ECL) detection kit (Amersham) as 
previously described by Ploug et al. [23]. The GLUT4 
antibody was a mouse monoclonal antibody produced 
against a synthetic peptide corresponding to the 13 C- 
terminal amino acids of GLUT4 [23]. 
Statistics. The statistical tests used were the unpaired 
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t-test, and the ANOVA test. Significance was set at the 
0.05 level of confidence. Results are presented as means + 
standard error of the mean (S.E.). 
3. Results 
The dose-response curve showed that vanadate inhib- 
ited the specific D-glucose uptake measured as total o- 
[3H]glucose uptake subtracted the unspecific L-[14C]glu - 
cose. Vanadate decreased the glucose uptake by maximally 
70% compared with the control preparation (Fig. 1). The 
dose-response curve displayed saturation and the maximal 
inhibition of glucose uptake was observed at 10 mmol 1- J. 
Furthermore, by visual inspection in a phase-contrast mi- 
croscope it was verified, that 2 h of incubation with 40 
mmol 1-1 vanadate at 34°C did not affect the number or 
the appearance of the vesicles compared with a control 
preparation. 
To further verify that vanadate inhibits glucose trans- 
port, vesicles were incubated for 2 h with 10 mmol 1-1 
vanadate at 34°C before being used for time-course studies 
of glucose uptake. The time-course of 5 mmol 1-= o-glu- 
cose zero-trans entry into membrane vesicles in the ab- 
sence or presence of vanadate is shown in Fig. 2. In 
agreement with the data in Fig. 1, vanadate caused a 
marked inhibition of D-glucose uptake in the vesicles. 
The glucose concentration dependence of the initial rate 
of glucose transport (measured as 30 s uptake) is shown in 
Fig. 3. In the control situation the Vma x was 358 ___ 50 pmol 
mg- I  protein s ~ and the Km was 24_5  mmol1-1 . In 
the presence of 10 mmol 1-1 vanadate, the Vma x was 
significantly reduced to 162 _ 18 pmol mg-1 protein s-1 
and the K~ was significantly decreased to 10 + 1 mmol 
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Fig. 1. Dose-response curve for vanadate action on glucose uptake. 
Vesicles were incubated at 34°C for 2 h with 3-40 mmol 1- I of NaVO 3. 
D-Glucose uptake was measured after 1 min of incubation with 5 mmol 
1 -n D-glucose, 0.5 /zCi D-[3H]glucose, and 0.1 /zCi L-[Inc]glucose. 
Values are means + S.E. of five determinations, each determination i
triplicate. CI, Control preparation; i ,  vanadate preparation. * P < 0.05 
compared with control. 
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Fig. 2. Time-course of specific D-glucose uptake measured at 5 mmol 1- 
D-glucose, 0.5 /zCi D-[3H]glucose, and 0,1 /xCi L-[~4C]glucose. Values 
are means+ S.E. of three determinations, each in duplicate. D, Control 
preparation; m, vanadate preparation. * P < 0.05 compared with control. 
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Fig. 3. Initial rate of specific D-glucose uptake as a function of external 
D-glucose concentration. The vesicles were incubated 2 h with 10 mmol 
1 t of NaVO 3. Glucose uptake was determined in duplicate at 2, 5, 10, 
20, 30 and 40 mmol 1- n of D-glucose. In the control the K m was 25 q- 5.1 
mmol 1 -~ and Vma x was 358-t-50 pmol mg -n total vesicle protein s -j 
and with vanadate the K m was 10+1.1 mmol 1 -n and Vm~ X was 
162 + 18 pmol mg-u total vesicle protein s-~. Values are means + S.E. 
of six preparations. D, Control preparation; i ,  vanadate preparation. 
The lines were drawn by using the calculated values of Vma x and Km. 
1 l (mean -t- S.E., n = 6, * P < 0.05 for both Vma ~ and 
Km). 
The GLUT4 protein content in the vesicles was mea- 
sured by Western blot after 2 h of incubation in the 
presence and absence of 10 mmol-1 of vanadate. Vana- 
date did not induce any significant change in the GLUT4 
content (control 4.41 + 0.25 arbitrary units; vanadate 4.49 
+ 0.27 arbitrary units, mean _ S.E., P = 0.71, n = 8). 
4. Discussion 
In this study of GLUT4 intrinsic activity, we have 
utilized a recently developed and characterized muscle 
plasma membrane vesicle preparation [23]. Characteriza- 
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tion of the vesicles showed that the vesicle membrane 
components are almost entirely of plasma membrane ori- 
gin since the plasma membrane marker K ÷ activated 
p-phenylphosphatase was enriched 37-fold [23]. Further- 
more, the vesicles are devoid of contamination with sarco- 
plasmic reticulum, T-tubuli or mitochondrial membranes 
[23,26] and GLUT1 could not be detected [23]. We found 
that the plasma membrane GLUT4 protein content was not 
changed in response to vanadate. Therefore the possibility 
of GLUT4 protein translocation can be, as expected, ex- 
cluded in this system. Hence, the preparation is well suited 
for studying changes in glucose transport via alterations in 
GLUT4 intrinsic activity. 
Vanadate has a wide range of metabolic effects [27]. 
Vanadate partially mimics the effects of insulin by stimu- 
lating GLUT4 translocation and glucose transport in rat 
adipocytes [1-3]. In particular, vanadate is a well-known 
phosphotyrosyl protein phosphatase inhibitor and insulin 
mediates at least some of its effects via an insulin-receptor 
associated tyrosine kinase. However, vanadate probably 
mimics the actions of insulin at a post-receptor level [1]. 
Recent reports suggest hat dephosphorylation f the 
GLUT4 isoform promotes its translocation from the intra- 
cellular storage site to the plasma membrane in adipocytes 
[15,18]. In contrast, increased phosphorylation of the 
GLUT4 is reported to decrease GLUT4 intrinsic activity in 
adipocytes [7,9-12,14,15]. In particular, it was found that 
streptozotocin-induced diabetes decreased the insulin- 
stimulated glucose transport by an increased GLUT4 pro- 
tein phosphorylation [15]. The increased GLUT4 phospho- 
rylation was restored by insulin therapy, whereas vanadate 
was ineffective [15]. In skeletal muscle, both insulin and 
vanadate stimulate glucose transport and yet vanadate is 
less effective in stimulating lucose transport compared 
with a maximal insulin stimulation [4-6]. Interestingly, 
Henriksen et al. [4] also found that insulin and vanadate in 
combination i creased glucose transport to a similar extent 
as insulin alone in skeletal muscle. The finding by Henrik- 
sen et al. [4] may suggest hat the GLUT4 protein is 
refractory to a vanadate-induced increase in phosphoryla- 
tion status when insulin is present. This is in accordance 
with an insulin-induced decrease in GLUT4 protein phos- 
phorylation as found in adipocytes [7,9-12,14,15]. All 
previous findings [4-7,9-12,14,15] taken together with the 
present findings, suggest that vanadate could inhibit a 
phosphotyrosyl phosphatase, thereby increasing the GLUT4 
phosphorylation status and decreasing the GLUT4 intrinsic 
activity. 
In contrast o our study, Okumura et al. [28] reported 
that vanadate nhanced glucose transport 4-5-fold in rat 
sarcolemmal vesicles. One explanation for this discrepancy 
could be differences in the method for producing plasma 
membrane vesicles. The preparation method of Okumura 
et al. [28] employs initial homogenization f the muscle. 
Vigorous homogenization produces contamination of the 
plasma membrane with tissue of non-muscular o igin, such 
as nerves and blood vessels. Since GLUT1 is localized in 
tissues with barrier functions [29], a substantial part of 
GLUT1 originates from perineural sheaths in muscle [30]. 
Thus, the preparation of Okumura et al. [28] probably 
contains GLUT1. This is supported by the fact that the 
preparation of Okumura et al. [28] is in fact prepared using 
the method of Grimditch et al. [31], which method is 
reported to give a preparation that does contain GLUT1 
[32,33]. In contrast, our preparation method does not in- 
clude homogenization f the tissue. Instead, vesicles are 
produced by bleb formation of the plasma membrane [23]. 
Therefore, our preparation contains very little if any 
GLUT1 [23]. Since Okumura et al. [28] reported that 
vanadate nhanced glucose uptake 5-6-fold in erythrocyte 
ghosts, which only contain GLUT1 [34], it is very likely 
that vanadate increased the glucose transport in their 
preparation by increased GLUT1 intrinsic activity. 
Due to the formation of plasma membrane blebs in our 
preparation method, substantial amounts of cytosolic pro- 
teins are enclosed - -  and trapped inside the plasma mem- 
brane spheres. In fact, approximately 90% of the total 
protein is lost after destruction of the vesicular structure, 
allowing removal of soluble intravesicular proteins [23]. 
Thus, our vesicle preparation could contain different pro- 
teins (including phosphotyrosine phosphatases) involved in 
increasing the GLUT4 intrinsic activity. 
In conclusion, in a giant vesicle preparation derived 
from rat sarcolemma, vanadate decreased glucose transport 
by reducing the GLUT4 intrinsic activity. 
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